Health Care: Drugs

Vermillion Inc (VRML: NASDAQ)

$2.219 n/a | n/a%
08/22/14 - 03:57 PM ET
Company Profile
Price and Volume
Recent Price 2.22
52 Week High 3.83
52 Week Low 1.50
Avg. Daily Vol. (Mil) 0.04
Beta (3 year) 1.85
Share Related Items
Mkt Cap (Mil) 79.66
Shares Out (Mil) 35.90
Float (Mil) 21.50
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.30
Current Ratio 6.50
LT Debt/ Equity 0.00
Total Debt / Equity 0.05
Valuation Ratios
Price Earnings n.a.
Price/Sales 31.32
Price/Book 3.47
Price/Cash Flow -7.80
Per Share Data
Earnings -0.38
Sales 0.07
Book Value 0.64
Cash Flow -0.28
Business Summary
Vermillion Inc is engaged in discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients with gynecologic cancers and related diseases.
General Information
12117 Bee Caves Road, Buildi
Suite 100
Austin, TX 78738
www.vermillion.com
Industry : Drugs
Sector: Health Care
Employees: 26
CEO: Mr. James T. LaFrance
Short Interest
Current Month (Mil) 0.83
Previous Month (Mil) 0.82
Short Interest Ratio (Days) 32.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -37.50
Return on Investments -44.60
Profitability
Gross Margin 95.70
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with VRML

Latest VRML Headlines from TheStreet

More Financial News for VRML

Press Releases for VRML

See All Press Releases

Partner Headlines for VRML

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter